Moreover, STMN1 and MET, but not HGF, expression showed potential capacity to predict taxane response in node-positive BC patients (AUC = 0.632 and AUC = 0.606, respectively), and a combined signature improved this score (AUC = 0.654), whereas HGF showed no discernable predictive capacity (Figure 1M–P). The gene discussed is MET; the disease is breast cancer.